dysautonomia

52
DYSAUTONOMIA PRESENTED BY: SIRTRARASAN BHARATHIDHASAN 1217 DATE: 27-11-2014 AUTONOMOUS NERVOUS SYSTEM AND ITS DYSFUNCTION 1

Upload: bharathi-dhasan

Post on 10-Feb-2017

160 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Dysautonomia

1

DYSAUTONOMIA

PRESENTED BY:

SIRTRARASAN BHARATHIDHASAN1217DATE: 27-11-2014

AUTONOMOUS NERVOUS SYSTEM AND ITS

DYSFUNCTION

Page 2: Dysautonomia

2

INTRODUCTION• Much of the action of the body in

maintaining, cardiovascular, gastrointestinal and thermal homeostasis occurs through the autonomic nervous system (ANS).

• The ANS is our primary defense against challenges, to maintain homeostasis. It provides involuntary control and organization of both maintenance and stress responses.

Page 3: Dysautonomia

3

HISTORY• GALEN - spoke of sympathy

& consent of body & was probably 1st to describe Paravertebral nerve trunks.

• THOMAS WILLIS notion of

involuntary movements

Page 4: Dysautonomia

4

JACOB WINSLOW COINED TERM ‘SYMPATHETIC’

ROBERT WHYTT recognized that adequate stimulation is necessary for visceral sensation & that all sympathy must be referred to brain

Page 5: Dysautonomia

5

XAVIER BICHAT divided nervous system into 2 parts

La vie organique- Visceral nervous system.

La vie animal- Somatic nervous system

CLAUDE BERNARD i) Theory of chemical

synapse transmission.ii) Described fundamental

role of ANS in maintaining Homeostasis (la fixite du milieu interior)

Page 6: Dysautonomia

6

BROWN-SEQUARD noted that sympathetic

stimulation constricts blood vessels.

• WALTER GASKELL described white communicanti rami & recognized that the system contained 2 antagonist set of nerve fibers.

Page 7: Dysautonomia

7

JOHN LANGLEY i) Mapped 3 distinct divisions in

system.ii) Coined term ‘AUTONOMIC’ &

declared thatit was largely independent from

brain.

SHERRINGTON initiated systemic study of

reflexes & described Characteristics of reflex function.

Page 8: Dysautonomia

8

JJ ABEL synthetized Epinephrine

• SIR HENRY DALE isolated Choline.

Page 9: Dysautonomia

9

DEFINITION• It is network of nerves & ganglia that

controls involuntary physiologic parameters & maintains internal homeostasis & stress responses.

• It is primarily peripheral efferent system.

• Autonomic - self governing

Page 10: Dysautonomia

10

PURPOSE OF AUTONOMIC NERVOUS SYSTEM

• A major goal of anesthetic administration is maintaining optimum homeostasis in the patient.

• The intelligent administration of anesthetic care to patients requires knowledge of ANS pharmacology in order to achieve desirable interactions of anesthetics with the involuntary control system and to avoid responses or interactions with deleterious effects.

Page 11: Dysautonomia

11

FUNCTIONAL ANATOMY Nervous System

Central Nervous System

Peripheral Nervous System

Somatic Autonomic

Sympathetic Parasympathetic

Enteric Nervous System

Page 12: Dysautonomia

12

Difference between

Somatic Autonomic

Organ supplied Skeletal muscles All other organs

Distal most synapse Within CNS Outside the CNS(i.e. ganglia)

Nerve fibers Myelinated Preganglionic - myelinated

Postganglionic- non

myelinated

Peripheral plexus

formation

Absent Present

Efferent transmitter ACH ACH, Nor-adrenaline

Effect of nerve section

on organ supplied

Paralysis and Atrophy Activity maintained, no

Atrophy

Page 13: Dysautonomia

13

Page 14: Dysautonomia

14

CENTRAL AUTONOMIC ORGANIZATION

• Cerebral cortex is the highest level of ANS integration.

• The principal ANS organization is the Hypothalamus.

• SNS functions are controlled by nuclei in the postero-lateral hypothalamus.

• PNS functions are governed by nuclei in the midline and some anterior nuclei of the hypothalamus.

• The anterior hypothalamus is involved in regulation of Temperature.

• The supra-optic hypothalamic nuclei regulates water metabolism.

Page 15: Dysautonomia

15

Page 16: Dysautonomia

16

Difference between Sympathetic Parasympathetic

Origin Dorso-lumbar (T1 to L2) Craniosacral (III, VII, IX, X, S2-

S4)

Distribution Wide Limited to head, neck and trunk

Ganglia Away from organs On / close to the organ

Post-ganglionic fibre Long Short

Pre-post ganglionic

fibre ratio

1:20 to 1:100 1:1 to 1:2 except in enteric

plexus

Transmitter Nor-adrenaline (major)

Acetylcholine (minor)

ACH

Stability of transmitter NA stable, differ for wider activity Ach rapidly destroyed locally

Imp. Function Tackling stress and emergency Assimilation of food,

conservation of energy

Page 17: Dysautonomia

17

Page 18: Dysautonomia

18

FUNCTIONS OF ANS

• Sympathetic – “Fight or flight”– “E” division• Exercise, excitement,

emergency, and embarrassment

• Parasympathetic – “Rest and digest”– “D” division• Digestion, defecation, and

diuresis

Page 19: Dysautonomia

19

AUTONOMIC DYSFUNCTION

Page 20: Dysautonomia

20

.• Dysautonomia is a condition in which the ANS malfunctions.It is an umbrella term used to denote many ANS disorders.It is a type of neuropathy affecting the nerves that carries information from the brain and spinal cord to various visceral organsThe diagnosis is achieved through the functional testing of the ANS,focussing on the affected organ system.

Page 21: Dysautonomia

21

CAUSES • Dysautonomia may be due to inherited or

degenerative neurological disorders[primary dusautonomia] or may be due to injury of ANS due to an acquired disorder[secondary dysautonomia

• Side effects of some drugs can cause abnormalities in the function of ANS,producing an iatrogenic form of dysautonomia

Page 22: Dysautonomia

22

.• Diabetes mellitus• Multiple sclerosis• Parkinson’s disease• HIV and AIDS• Amyloidosis• Boutilism• Pure autonomic failure• Lyme disease amd Tuberculosis• Lupus,Sjogen’s syndrome,sarcodiasis[A-I disorders]• Chronic alcohol misuse• Spinal cord injury• Physical trauma or injury

Page 23: Dysautonomia

23

.• Signs and symptoms• The symptoms of dysautonomia are numerous and vary widely from

person to person depending on the nerves affected and underlying cause. Symptoms often develop gradually over years. Each patient with dysautonomia is different—some are affected only mildly, while others are often left disabled.

• The primary symptoms present in patients with dysautonomia include:• Excessive fatigue• Excessive thirst (polydipsia)• Lightheadedness or dizziness, often associated with

orthostatic hypotension (abnormally low blood pressure on standing), sometimes resulting in syncope (fainting)

• Rapid heart rate or slow heart rate• Blood pressure fluctuations• Difficulty with breathing or swallowing

Page 24: Dysautonomia

24

..

• Shortness of breath with activity or exercise• Distension of the abdomen• Mydriasis (abnormal dilation of the pupils) leading to

blurry vision• Urinary incontinence or neurogenic bladder dysfunction• Gastroparesis (delayed gastric emptying) with

associated nausea, acid reflux and vomiting• Constipation• Excessive sweating or lack of sweating (ahydrosis)• Heat intolerance brought on with activity and exercise• Sexual problems including erectile dysfunction in men

and vaginal dryness and orgasmic difficulties in women

Page 25: Dysautonomia

25

TESTS OF AUTONOMIC SYSTEM FUNCTION

• These tests measure how the various systems in the body, controlled by autonomic nerves, respond to stimulation. The data collected during testing will indicate functioning of ANS.

• These tests help to identify patients with autonomic neuropathy and is predictive of mortality and morbidity.

• Early autonomic dysfunction is defined as a single abnormal or two borderline-abnormal results on the tests involving changes in heart rate.

• Definite involvement comes when two of the tests of changes in heart rate are abnormal. Severe dysfunction is defined as abnormalities in the blood pressure assessments.

• Tests are done to monitor BP, blood flow, heart rate, skin temperature and sweating

Page 26: Dysautonomia

26

Indications for ANS testing

• Syncope[sudden loss of consciousness]• Central autonomic degeneration ex. Parkinsons• Pure autonomic failure• Postural tachycardia syndrome• Autonomic and small fiber peripheral

neuropathies ex.- diabetic neuropathy• Sympathetically mediated pain• Evaluating response to therapy• Differentiating benign symptoms from

autonomic disorders

Page 27: Dysautonomia

27

VALSALVA MANOEUVER

• It is performed by moderately forceful attempted exhalation against a closed airway,

• Usually done by closing one’s mouth,pinching one’s nose shut while pressing out asif blowing up a balloon

• This is used for medical examination, as a test of cardiac function and autonomic nervous control of heart or to clear the ears and sinuses during ambint changes happens during diving,hyperbaric oxygen therapy,and air travel

Page 28: Dysautonomia

28

Page 29: Dysautonomia

29

Parasympathetic function testsHR response with valsalva manoeuver

• Valsalva manoeuver: valsalva ratio is an index of HR response to BP changes that occur during valsalva manoeuver resulting from mechanical and cardiovascular effects.

• Measure baseline HR and BP 3 minutes before this test• Patient takes a deep inhalation, a complete

exhalation, inhales again and then blows into a mouthpiece for 15 seconds

• Expiratory pressure is maintained at 40 mm Hg. This pressure can be measured by having the patient to exhale through a mouth piece attached to a transducer

Page 30: Dysautonomia

30

• BP and HR are measured throughout the manoeuver for 60 seconds after temination of the manoeuver

• An average of 2 trials are taken for analysis

• Caution while performing the test in elderly with pulmonary disease who may not be able to perform the test satisfactorily

• As intraocular pressure is known to rise, the test must not be performed in those with recent retinal surgery

• VR values are aggregated. There is a decrease with age.

Page 31: Dysautonomia

31

• VR=Max HR/Min HR. a normal VR indicates an intact baroreceptor mediated increase and decrease in HR. a decreased VR reflects baroreceptor and cardiovagal dysfunction. Normal value is a ratio of >1.21

Stimulus Expiration of 40mm Hg for 15sec.

Afferent Baroreceptors, Glossopharyngeal & Vagus nerves.

Central Nucleus Tractus Solitarus

Efferent Vagus & sympathetic nervous system.

Response Heart rate response to blood pressure changesIncrease/Decrease in BP (phases I-IV)

Page 32: Dysautonomia

32

HR variability with respiration (respiratory sinus arrhythmia)

• Respiratory sinus arrhythmia is recorded with patient supine & breathing at fixed rate of 6 breaths/min with slow inhalation & exhalation. This provides close to maximum HR variability.

• 6-8 cycles are recorded with one or two trials being performed.

• Timed breathing potentiates normal sinus arrhythmia that occurs during the normal respiratory cycles

• Reduced HR variability with respiration is seen in aging, autonomic peripheral neuropathies and central autonomic degenerations.

• Other factors which can influence this test are poor respiratory efforts, hypercapnia, salicylates poisoning, obesity

Page 33: Dysautonomia

33

• E/I Ratio: sum of longest RR intervals divided by sum of shortest RR intervals. Normal value is a mean difference of >15 BPM.

Stimulus Deep breathing (6cycles/min)

Afferent Pulmonary receptors, Cardiac mechanoreceptors, Vagus & Glossopharyngeal nerves, Respiratory centre.

Center Nucleus tractus solitaries

Efferent Vagus

Response Heart rate increases during Inspiration.Heart rate decreases during Expiration.

Page 34: Dysautonomia

34

The 30:15 ratio (HR response to standing)

• With patient in supine position baseline HR is measured

• Patient is asked to quickly stand up• HR variability is measured for at least 1 min of

active standing• A normal ratio is greater than 1 & reflects intact

vagally mediated HR changes.• An abnormal ratio indicates parasympathetic

cardiovagal dysfunction• Misinterpretations of this test can occur in

hypovolemia, medical deconditioning, and hypothyroidism.

Page 35: Dysautonomia

35

After standing HR ↑ Exercise, reflex/withdrawl of

parasympathetic tone.

Approx 15sec later HR ↑↑ Compensatory response to decreased venous return, cardiac output & BP.

At approx 30 sec Relative bradycardia

Stimulus Decreased central blood volume.

Afferent Baroreceptors, Ergoreceptors, Vagus & Glossopharyngeal nerves.

Center Nucleus tractus solitaries, Rostral ventrolateral medulla.

Efferent Vagus

Response HR increases at approx 15 sec.HR decreases at approx 30 sec.

Page 36: Dysautonomia

36

Sympathetic function tests

Blood pressure response to sustained hand grip

• Sustained hand grip causes reflex increase in heart rate & cardiac output without changing systemic vascular resistance.

• Diastolic BP thus normally increases.• BP is measured every min for 5 min.• The initial diastolic BP is substracted from the

diastolic BP just before release.• The normal value is difference of >16mm

Hg.

Page 37: Dysautonomia

37

Blood pressure response to standing

• The patient moves from resting supine to standing position.

• The standing Systolic BP is substracted from the supine Systolic BP.

• The normal value is difference of <10mm Hg.

Page 38: Dysautonomia

38

Head Up Tilt Table Test

• This test determines BP & HR response to an orthostatic challenge as a measure of sympathetic function.

• Used to access orthostatic intolerance caused by sympathetic nervous system dysfunction & to detect any predisposition to vasovagal syncope.

• Patient lies supine on a tilt table & a belt is placed around the waist to secure them in case of syncope.

• BP & ECG are monitored throughout the tests & recorded.

• Baseline BP is recorded for atleast 3 min.

Page 39: Dysautonomia

39

• Patient is slowly tilted upright to an angle of 60-80°.

• Patient is asked to report any symptoms.• Patient is returned to horizontal supine

position.• HR & BP are monitored in supine position

until it returns to baseline.• IV Isoproterenol, a pharmacological

measure to potentiate orthostatic challenge to the tilt table test, is frequently used.

• A normal tilt table test is one in which there are no symptoms & a modest fall in BP.

Page 40: Dysautonomia

40

Stimulus Decreased central blood volume.

Afferent Baroreceptors, Vagus & Glossopharyngeal nerves

Center Nucleus Tractus Solitarus, Rostral ventrolateral medulla, Hypothalamus.

Efferent Sympathetic vasomotor

Response Pattern, degree & rate of BP changes.HR increase/decrease.3 patterns: a)Vasodepression resulting in hypotension without bradycardia.b)Marked bradycardia (<40/min) with or without fall in BP.c)Both bradycardia & Hypotension.

Page 41: Dysautonomia

41

• Other tests used are-– Sympathetic Cholinergic Sweat Function– Quantitative Sudomotor Axon Reflex

Test.– Silastic Imprint Test.– Thermoregulatory Sweat Test.–Microneurography.

Page 42: Dysautonomia

42

DISEASES ASSOCIATED WITH PROGRESSIVE

NEUROLOGICAL IMPAIRMENT OF

AUTONOMIC NERVOUS SYSTEM

Page 43: Dysautonomia

43

• They can be primary, familial or due to secondary systemic disease or idiopathic.

Primary :• 1. Idiopathic Orthostatic Hypotension• 2. Shy-Drager type of Orthostatic

Hypotension Familial :• 1. Riley-Day Syndrome (Autonomic

neuropathy in infants and children)• 2. Lesch-Nyhan Syndrome• 3. Gill Familial dysautonomia

Page 44: Dysautonomia

44

Secondary to systemic diseases:• Aging• Diabetes Mellitus• Chronic Alcoholism • Chronic Renal Failure• Hypertension• Rheumatoid Arthritis • Carcinomatosis• Chaga's disease • Tetanus• Spinal cord injury – Transection

– Acute – Chronic

• Neurological diseases– Tabes Dorsalis – Syringomyelia – Amyloidosis

Page 45: Dysautonomia

45

Ageing• Approximately 20% of people over 65 years of age

have postural hypotension.

• Half of these patients are symptomatic i.e they experience dizziness, faintness or loss of consciousness.

• It is well known that the reflex regulation of heart rate which is mediated primarily by parasympathetic mechanisms declines progressively with age.

• There will be a selective or earlier impairment of parasympathetic function with aging with a minimal or a more gradual involvement of the sympathetic nervous system

Page 46: Dysautonomia

46

Diabetes Mellitus• Diabetic autonomic neuropathy is a well known clinical

entity. It may result from neuronal degeneration or metabolically related neuronal dysfunction.

• The afferent central or efferent reflex pathways each can be involved.

• It has been suggested that the Vagal neuropathy occurs earlier in the course of DM than the sympathetic neuropathy.

• The most sensitive test of cardiac parasympathetic impairment is that of determining RSA during forceful breathing. Intolerance to upright posture is often evident. The presence of symptomatic postural hypotension is associated with a poor prognosis. These patients are prone to sudden cardiac death.

Page 47: Dysautonomia

47

For those scheduled for surgery there are several implications that are important to anaesthesiologist.

• Esophageal dysfunction and gastric hypotonia increase the risk of regurgitation and aspiration.

• Bradycardia, hypotension and cardiopulmonary arrest have been reported.

• Abnormal blood pressure falls with induction and highest requirement for intraoperative pressor agents to maintain stable haemodynamics.

• ANS dysfunction may also interfere with control of ventilation, making diabetics more susceptible to respiratory depressant effects of drugs.

• Painless myocardial infarction and unexplained cardio respiratory arrest have been reported.

Page 48: Dysautonomia

48

Autonomic changes in Spinal Cord Transection

• It can cause various degrees of autonomic dysfunction depending on site, extent & timing of the lesion.

• Many autonomic reflexes are inhibited by Supraspinal feedback that is lost after spinal cord transaction.

• In Paraplegic patient, small stimuli can cause exaggerated sympathetic discharges.

• The only intact efferent component of baroreflex pathways in Quadriplegic patients is Vagus.

• There are fundamental differences between acute & chronic spinal cord transaction.

Page 49: Dysautonomia

49

• First, a transient state of decreased excitability occurs, known as Spinal Shock. It may last for days to weeks. – In these patients, the periphery is generally atonic

& peripheral blood vessels are dilated.– In case of recent High Thoracic lesion, basal supine

blood pressure is usually low & accompanied by plasma catecholamine levels that are approx 35% of normal.

– In case of recent Low spinal injuries, compensatory tachycardia is exhibited from intact part of ANS.

– In cases of chronic High spinal lesion, patient may fail to respond to hypovolemia with increased heart rate & may exhibit bradycardia. Renin-angiotensin-aldosterone system compensates for maintenance of blood pressure in these patients.

Page 50: Dysautonomia

50

• The phenomenon of Autonomic dysreflexia can occur with stimulation below the lesion.

• Bladder & bowel distension can elicit Mass Reflex.– Dramatic rise in blood pressure.–Marked reduction in flow to periphery.– Flushing & sweating in areas above the

lesion.– In addition there may be contraction of

bladder & bowel, skeletal muscle spasm & penile erection.

Page 51: Dysautonomia

51

PREVENTION AND TREATMENT OF ADVERSE AUTONOMIC REFLEXES

• Atropine commonly used for both prevention and treatment.

• Topical anaesthesia can eliminate the reflex.• Intravenous lidocaine is more effective than topical

anaesthesia.• Cessation of applied stimulus immediately.• Vasopressors injected if there is persistent hypotensive

response.• Depth of anaesthesia should be increased. Most of the

intrathoracic and intraabdominal reflexes are observed during surgery when anaesthesia is to light or relaxation is inadequate.

Page 52: Dysautonomia

52

REFERENCES1. Miller`s Anaesthesia- 7th ed.2. Barash Clinical Anesthesia- 6th ed.3. Stoelting`s Principles of Anesthesiology-3rd

ed.4. Collin`s Anesthesiology5. Ganong`s Review of Medical Physiology-23rd

ed.6. K.D Tripathi`s Essentials of Medical

Pharmacology 5th ed. 7. ISACON 2009.